MET and cancer: Anaplastic lymphoma kinase (ALK) (6), hepatocyte growth factor receptor (HGFR/c-Met) (7), and ROS proto-oncogene 1 receptor tyrosine kinase (ROS1) (8) are tyrosine receptor kinases, implicated to be aberrantly expressed in human cancers (9–11).